世界中医药
文章摘要
引用本文:史金玉1,王超2,黄乐曦1,赵海滨2.冠心病合并焦虑抑郁的治疗研究进展[J].世界中医药,2022,(14):.  
冠心病合并焦虑抑郁的治疗研究进展
Research Progress in the Treatment of Coronary Heart Disease with Anxiety and Depression
投稿时间:2020-10-31  
DOI:10.3969/j.issn.1673-7202.2022.14.024
中文关键词:  冠心病  焦虑  抑郁  发病机制  治疗方式
English Keywords:Coronary heart disease  Anxiety  Depression  Pathogenesis  Treatment
基金项目:首都临床特色应用研究与成果推广项目(Z161100000516136)
作者单位
史金玉1,王超2,黄乐曦1,赵海滨2 1 北京中医药大学北京100029 2 北京中医药大学东方医院北京100078 
摘要点击次数: 361
全文下载次数: 0
中文摘要:
      冠心病合并焦虑抑郁的发病率逐年升高,但是识别率和诊治率较低。目前西医认为其发病机制可能与炎症反应、神经内分泌学说、血小板活化、内皮损伤等相关;中医认为气血阴阳亏损以及气滞、血瘀、痰浊为主要病因病机。治疗方式主要是在冠心病二级预防的基础上,联合中西医药物及非药物治疗焦虑抑郁,有效控制其危险因素。现主要对冠心病合并焦虑抑郁的发病机制及治疗进展进行报道。
English Summary:
      The morbidity of coronary heart disease with anxiety and depression increases year by year,but its recognition rate and diagnosis and treatment rate are low.At present,western medicine believes that the pathogenesis of coronary heart disease with anxiety and depression may be related to inflammatory reaction,neuroendocrine system,platelet activation,endothelial injury,etc.,while traditional Chinese Medicine(TCM) holds that the deficiency of Qi,blood,Yin and Yang,Qi stagnation,blood stasis,turbid phlegm are the main etiology and pathogenesis.The treatment is mainly based on secondary prevention of coronary heart disease,combined with traditional Chinese and western medicine and non-drug treatment of anxiety and depression,to effectively control the risk factors.This paper reviewed the pathogenesis and treatment of coronary heart disease with anxiety and depression.
查看全文  查看/发表评论  下载PDF阅读器